A mechanism based approach to management of children with end-stage liver disease

References

• Yazigi NA. Term outcomes Long after pediatric liver transplantation. Pediatr Gastroenterol Hepatol Nutr. 2013;16:207–218.
   PubMedGoogle Scholar
• Kelly DA. Current results and evolving indications for liver transplantation in children. J Pediatr Gastroenterol Nutr. 1998;27:214–221.
   PubMed Web of Science ®Google Scholar
• Jain A, Mazariegos G, Kashyap R, et al. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002;73:941–947.
   PubMed Web of Science ®Google Scholar
• Farmer DG, Venick RS, McDiarmid SV, et al. Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single institution. J Am Coll Surg. 2007;204:904–914.
   PubMed Web of Science ®Google Scholar
• Sokal EM, Goldstein D, Ciocca M, et al. End-stage liver disease and liver transplant: current situation and key issues. J Pediatr Gastroenterol Nutr. 2008;47:239–246.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Fernández J. Management of hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol. 2011;7:517–526.
   PubMed Web of Science ®Google Scholar
• Pinto RB. Cirrhosis in children and adolescents: an overview. World J Hepatol. 2015;7:392–405.
   PubMed Web of Science ®Google Scholar
• Triantos C, Kalafateli M. Endoscopic treatment of esophageal varices in patients with liver cirrhosis. ‎World J Gastroenterol. 2014;20:13015– 13026.
   PubMed Web of Science ®Google Scholar
• Wang KS, Tiao G, Bass LM, et al. Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis. Hepatology. 2016;00:1–10.
   Google Scholar
• Thébaut A, Habes D, Gottrand F, et al. Sertraline as an additional treatment for cholestatic pruritus in children. J Pediatr Gastroenterol Nutr. 2016;64:431–435.
   Web of Science ®Google Scholar
• Mittal A. Cholestatic itch management. In: Jacek C. Szepietowski, Elke Weisshaar, Editors. Current problems in dermatology. 2016;50:142–148.
   Google Scholar
• Laviano A, Cangiano C, Preziosa I, et al. Plasma tryptophan levels and anorexia in liver cirrhosis. Int J Eat Disord. 1997;21:181–186.
   PubMed Web of Science ®Google Scholar
• Testa R, Franceschini R, Giannini E, et al. Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol. 2000;33:33–37.
   PubMed Web of Science ®Google Scholar
• Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology. 1997;26:40–48.
   PubMed Web of Science ®Google Scholar
• Hammad A, Kaido T, Uemoto S. Perioperative nutritional therapy in liver transplantation. Surg Today. 2015;45:271–283.
   PubMed Web of Science ®Google Scholar
• Thuluvath PJ, Triger DR. Autonomic neuropathy and chronic liver disease. Q J Med. 1989;72:737–747.
   PubMedGoogle Scholar
• Xu K, Morgan KT, Todd Gehris A, et al. A whole-body model for glycogen regulation reveals a critical role for substrate cycling in maintaining blood glucose homeostasis. PLoS Comput Biol. 2011;7:e1002272.
   PubMed Web of Science ®Google Scholar
• McCullough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Semin Liver Dis. 1991;11:265–277.
   PubMed Web of Science ®Google Scholar
• Baker A, Stevenson R, Dhawan A, et al. Guidelines for nutritional care for infants with cholestatic liver disease before liver transplantation. Pediatr Transplant. 2007;11:825–834.
   PubMed Web of Science ®Google Scholar
• Ferreira LG, Ferreira Martins AI, Cunha CE, et al. Negative energy balance secondary to inadequate dietary intake of patients on the waiting list for liver transplantation. Nutrition. 2013;29:1252–1258.
   PubMed Web of Science ®Google Scholar
• Müller MJ, Böttcher J, Selberg O, et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr. 1999;69:1194–1201.
   PubMed Web of Science ®Google Scholar
• Ferreira LG, Santos LF, Silva TRN, et al. Hyper- and hypometabolism are not related to nutritional status of patients on the waiting list for liver transplantation. Clin Nutr. 2014;33:754–760.
   PubMed Web of Science ®Google Scholar
• Högler W, Baumann U, Kelly D. Endocrine and bone metabolic complications in chronic liver disease and after liver transplantation in children. J Pediatr Gastroenterol Nutr. 2012;54:313–321.
   PubMed Web of Science ®Google Scholar
• Dasarathy S. Consilience in sarcopenia of cirrhosis. J Cachexia Sarcopenia Muscle. 2012;3:225–237.
   PubMed Web of Science ®Google Scholar
• Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol. 2014;20:8061–8071.
   PubMed Web of Science ®Google Scholar
• Pierro A, Koletzko B, Carnielli V, et al. Resting energy expenditure is increased in infants and children with extrahepatic biliary atresia. J Pediatr Surg. 1989;24:534–538.
   PubMed Web of Science ®Google Scholar
• Greer R, Lehnert M, Lewindon P, et al. Body composition and components of energy expenditure in children with end-stage liver disease. J Pediatr Gastroenterol Nutr. 2003;36:358–363.
   PubMed Web of Science ®Google Scholar
• Sokol RJ, Stall C. Anthropometric evaluation of children with chronic liver disease. Am J Clin Nutr August. 1990;52:203–208.
   PubMed Web of Science ®Google Scholar
• Johnson TM, Overgard EB, Cohen AE, et al. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract. 2013;28:15–29.
   PubMed Web of Science ®Google Scholar
• Ramaccioni V, Soriano HE, Arumugam R, et al. Nutritional aspects of chronic liver disease and liver transplantation in children. J Pediatr Gastroenterol Nutr. 2000;30:361–367.
   PubMed Web of Science ®Google Scholar
• Protheroe SM, Kelly DA. Cholestasis and end-stage liver disease. Baillière’s Clin Gastroenterol. 1998;12:823–841.
   PubMed Web of Science ®Google Scholar
• Chin SE, Shepherd RW, Cleghorn GJ, et al. Survival, growth and quality of life in children after orthotopic liver transplantation: a 5 year experience. J Paediatr Child Health. 1991;27:380–385.
   PubMed Web of Science ®Google Scholar
• Kelly DA. Nutritional factors affecting growth before and after liver transplantation. Pediatr Transplant. 1997;1:80–84.
   PubMedGoogle Scholar
• Merli M, Giusto M, Gentili F, et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int. 2010;30:208–214.
   PubMed Web of Science ®Google Scholar
• DiMartini A, Cruz RJ, Dew MA, et al. Muscle mass predicts outcomes following liver transplantation. Liver Transpl. 2013;19:1172–1180.
   PubMed Web of Science ®Google Scholar
• Ney M, Abraldes JG, Ma M, et al. Insufficient protein intake is associated with increased mortality in 630 patients with cirrhosis awaiting liver transplantation. Nutr Clin Pract. 2015;30:530–536.
   PubMed Web of Science ®Google Scholar
• Nightingale S, Ng VL. Optimizing nutritional management in children with chronic liver disease. Pediatr Clin North Am. 2009;56:1161–1183.
   PubMed Web of Science ®Google Scholar
• Holt RI, Miell JP, Jones JS, et al. Nasogastric feeding enhances nutritional status in paediatric liver disease but does not alter circulating levels of IGF-I and IGF binding proteins. Clin Endocrinol (Oxf). 2000;52:217–224.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Osaki Y. Liver cirrhosis: evaluation, nutritional status, and prognosis. Mediators Inflamm. 2015;2015:1–9.
   Web of Science ®Google Scholar
• Becker P, Carney LN, Corkins MR, et al. Consensus statement of the academy of nutrition and dietetics/American Society for Parenteral and Enteral Nutrition: indicators recommended for the identification and documentation of pediatric malnutrition (undernutrition). Nutr Clin Pract. 2015;30:147–161.
   PubMed Web of Science ®Google Scholar
• Bates J, McClain CJ. The effect of severe zinc deficiency on serum levels of albumin, transferrin, and prealbumin in man. Am J Clin Nutr. 1981;34:1655–1660.
   PubMed Web of Science ®Google Scholar
• Müller MJ, Lautz HU, Plogmann B, et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology. 1992;15:782–794.
   PubMed Web of Science ®Google Scholar
• Mouzaki M, Ng V, Frcp C, et al. Enteral energy and macronutrients in end-stage liver disease. J Parenter Enteral Nutr. 2014;38:673–681.
   PubMed Web of Science ®Google Scholar
• Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care. 2003;6:79–85.
   PubMed Web of Science ®Google Scholar
• McCullough AJ, Mullen KD, Tavill AS, et al. In vivo differences between the turnover rates of leucine and leucine’s ketoacid in stable cirrhosis. Gastroenterology. 1992;103:571–578.
   PubMed Web of Science ®Google Scholar
• A.S.P.E.N. Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. J Parenter Enteral Nutr. 2002;26:1SA–38SA.
   PubMed Web of Science ®Google Scholar
• Patel SP, Lynch RJ, He K, et al. Central sarcopenia and post-liver transplant mortality. J Surg Res. 2010;158:408–409.
   Google Scholar
• Tandon P, Ney M, Irwin I, et al. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl. 2012;18:1209–1216.
   PubMed Web of Science ®Google Scholar
• Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle. 2015;6:197–207.
   PubMed Web of Science ®Google Scholar
• Argilés JM, Busquets S, Stemmler B, et al. Cachexia and sarcopenia: mechanisms and potential targets for intervention. Curr Opin Pharmacol. 2015;22:100–106.
   PubMed Web of Science ®Google Scholar
• Squires RH, Ng V, Romero R, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362–398.
   PubMed Web of Science ®Google Scholar
• Young S, Kwarta E, Azzam R, et al. Nutrition assessment and support in children with end-stage liver disease. Nutr Clin Pract. 2013;28:317–329.
   PubMed Web of Science ®Google Scholar
• Shneider BL, Magee JC, Bezerra JA, et al. Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia. Pediatrics. 2012;130:e607–14.
   PubMed Web of Science ®Google Scholar
• Feranchak AP, Gralla J, King R, et al. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology. 2005;42:782–792.
   PubMed Web of Science ®Google Scholar
• Sultan MI, Leon CDG, Biank VF. Role of nutrition in pediatric chronic liver disease. Nutr Clin Pract. 2011;26:401–408.
   PubMed Web of Science ®Google Scholar
• Nicolaidou P, Georgouli H, Kotsalis H, et al. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol. 2006;21:205–209.
   PubMed Web of Science ®Google Scholar
• Argao EA, Heubi JE, Hollis BW, et al. d-Alpha-tocopheryl polyethylene glycol-1000 succinate enhances the absorption of vitamin D in chronic cholestatic liver disease of infancy and childhood. Pediatr Res. 1992;31:146–150.
   PubMed Web of Science ®Google Scholar
• Sokol RJ. Assessing vitamin E status in childhood cholestasis. J Pediatr Gastroenterol Nutr. 1987;6:10–13.
   PubMed Web of Science ®Google Scholar
• Umusig-Quitain P, Gregorio GV. High incidence of zinc deficiency among Filipino children with compensated and decompensated liver disease. J Gastroenterol Hepatol. 2010;25:387–390.
   PubMed Web of Science ®Google Scholar
• Wagatsuma A, Sakuma K. Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res Int. 2014;2014:1–13.
   Web of Science ®Google Scholar
• Tanner SB, Harwell S. More than healthy bones: a review of vitamin D in muscle health. Ther Adv Musculoskelet Dis. 2015;7:152–159.
   PubMed Web of Science ®Google Scholar
• Hamilton B. Vitamin D and human skeletal muscle. Scand J Med Sci Sports. 2010;20:182–190.
   PubMed Web of Science ®Google Scholar
• Heckmann SM, Hujoel P, Habiger S, et al. Zinc gluconate in the treatment of dysgeusia – a randomized clinical trial. J Dent Res. 2005;84:35–38.
   PubMed Web of Science ®Google Scholar
• Ginés P, Quintero E, Arroyo V, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 1987;7:122–128.
   PubMed Web of Science ®Google Scholar
• Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–488.
   PubMed Web of Science ®Google Scholar
• Schrier RW, Arroyo V, Bernardi M, et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;8:1151–1157.
   PubMed Web of Science ®Google Scholar
• Ginés P, Berl T, Bernardi M, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology. 1998;28:851–864.
   PubMed Web of Science ®Google Scholar
• Arroyo V, Ginés P, Planas R, et al. Management of patients with cirrhosis and ascites. Semin Liver Dis. 1986;6:353–369.
   PubMed Web of Science ®Google Scholar
• Quittnat F, Gross P. Vaptans and the treatment of water-retaining disorders. Semin Nephrol. 2006;26:234–243.
   PubMed Web of Science ®Google Scholar
• Ginès P. Vaptans: a promising therapy in the management of advanced cirrhosis. J Hepatol. 2007;46:1150–1152.
   PubMedGoogle Scholar
• Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet. 2008;371:1624–1632.
   PubMed Web of Science ®Google Scholar
• O’Leary JG, Davis GL. Conivaptan increases serum sodium in hyponatremic patients with end-stage liver disease. Liver Transpl. 2009;15:1325–1329.
   PubMed Web of Science ®Google Scholar